Assessment of Antibody Response of a Boosted Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Children Previously Immunized With a Single Dose of JE-CV

NCT01954810 Phase 4 UNKNOWN

This study has aim to describe the immune response to the second dose of Japanese encephalitis chimeric vaccine (JECV) in children previously vaccinated with one dose of JECV 5 years ago.

Details

Lead sponsor	Khon Kaen University
Phase	Phase 4
Status	UNKNOWN
Enrolment	88
Start date	2013-10
Completion	2014-05

Conditions

• Japanese Encephalitis

Interventions

• Japanese encephalitis chimeric vaccine (JECV)

Primary outcomes

• Neutralizing antibody titers after JECV vaccination — 28 days
  Neutralizing antibody titers before JECV booster (on D0), and after IMOJEV booster (on D28)

Countries

Thailand